Consistent with this, a recent postmortem human brain study demonstrated that VGLUT2‐expressing midbrain DA neurons are more resilient in PD patients (Steinkellner et al. 2022), indicating this mechanism's clinical relevance. The gene discussed is SLC17A6; the disease is Parkinson disease.